INSIGHTS ON CELL & GENE THERAPY DISCOVERY

• Collaboration An Untapped Fuel For Driving Biopharma R&D

  Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.

• The Immune System's Secret Language: Unlocking Cellular Communication

  The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.

• Measuring AAV Vector Genome Titer Using Droplet Digital PCR Protocol

  Achieve highly consistent and precise AAV vector genome titer measurements with this optimized ddPCR protocol. This method ensures accurate dosing and optimal cell therapy potency.

• Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays

  Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

• Use Of Epiontis ID In A Phase 2 Psoriasis Trial

  Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.

• How AI & Biomarkers Are Reshaping The Next Frontier In Drug Development

  Learn more about the importance of biomarker-driven drug development and the integration of laboratory science, clinical expertise, and regulatory strategy to accelerate targeted therapy development.

• Enhancing Throughput And Reproducibility In Proteomic Analysis

  Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.

• Improving The Efficiency And Quality Of Advanced Imaging And Analysis

  Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.

• Variant-Aware Off-Target Analysis For Informed Guide RNA Selection

  See how a multi-step, variant-aware approach to CRISPR-based guide RNA selection systematically reduces off-target risk at each stage, giving researchers greater confidence in their work.

• ASCO 2025: Key Takeaways From The American Society Of Clinical Oncology Annual Meeting

  Cell and gene therapy for cancer continues to advance. New data show promise, alongside discussions on safety and scalability.